ncpr.bg

REPUBLIC OF BULGARIA

NATIONAL COUNCIL ON PRICES AND REIMBURSEMENT OF MEDICINAL PRODUCTS

ncpr.bg
  • Bulgarian (BG)
  • English (UK)
  • Bulgarian (BG)
  • English (UK)
  • For citizens
  • For business
  • Home
  • NCPRMP
    • About Council
    • Composition
    • Structure
    • Code of ethics
    • Annual reports
  • Regulations
    • European Legislation
    • Bulgarian Legislation
      • Legislation
      • Regulations
      • Tariffs
  • Administrative Services
    • Еlectronic administrative services
    • Procedure for provision of administrative services
    • Document templates
    • Procedure for appealing the acts issued by the NCPR
    • Administrative Service Center
    • Bank account
    • Notifications under Art. 61 para. 3 of APC
    • Suggestions and alerts
    • Access to public information
  • Registers
    • Electronic registers
    • Annex № 1 to PDL
    • Annex № 2 to PDL
    • Annex № 3 to PDL
    • Annex № 4 to PDL
    • Ceiling prices register
    • Maximum sales prices register
    • Archive of registers
      • Archive of registers for 2013
      • Archive of registers for 2014 г.
      • Archive of registers for 2015 г.
  • Prices and Reimbursement
    • Reference states
    • Instructions
    • Schedule for ex offcio check under Art 43
    • List of decisions issued to maintain reimbursement status
  • Health Technology Assessment
    • Regulations
    • Summary of HTA reports
      • Positive decision for inclusion in PDL
      • Negative decision for inclusion in PDL
    • Horizon scanning
    • HTA Coordination Group (HTACG)
    • Heads of HTA Agencies group
    • Initiative and events
  • Monitoring the effect of therapy
  • Pharmacotherapeutic guidances
ncpr.bg

РЕПУБЛИКА БЪЛГАРИЯ

НАЦИОНАЛЕН СЪВЕТ ПО ЦЕНИ И РЕИМБУСИРАНЕ НА ЛЕКАРСТВЕНИ ПРОДУКТИ

ncpr.bg
  • Bulgarian (BG)
  • English (UK)
  • For citizens
  • For business
  • Home
  • NCPRMP
    • About Council
    • Composition
    • Structure
    • Code of ethics
    • Annual reports
  • Regulations
    • European Legislation
    • Bulgarian Legislation
      • Legislation
      • Regulations
      • Tariffs
  • Administrative Services
    • Еlectronic administrative services
    • Procedure for provision of administrative services
    • Document templates
    • Procedure for appealing the acts issued by the NCPR
    • Administrative Service Center
    • Bank account
    • Notifications under Art. 61 para. 3 of APC
    • Suggestions and alerts
    • Access to public information
  • Registers
    • Electronic registers
    • Annex № 1 to PDL
    • Annex № 2 to PDL
    • Annex № 3 to PDL
    • Annex № 4 to PDL
    • Ceiling prices register
    • Maximum sales prices register
    • Archive of registers
      • Archive of registers for 2013
      • Archive of registers for 2014 г.
      • Archive of registers for 2015 г.
  • Prices and Reimbursement
    • Reference states
    • Instructions
    • Schedule for ex offcio check under Art 43
    • List of decisions issued to maintain reimbursement status
  • Health Technology Assessment
    • Regulations
    • Summary of HTA reports
      • Positive decision for inclusion in PDL
      • Negative decision for inclusion in PDL
    • Horizon scanning
    • HTA Coordination Group (HTACG)
    • Heads of HTA Agencies group
    • Initiative and events
  • Monitoring the effect of therapy
  • Pharmacotherapeutic guidances

Information

  • Anticorruption
  • Public procurement
  • Careers
  • Administrative register
  • Open Data

Positive decision to include a medicinal product belonging to a new international non-proprietary name (INN) 2020

BIKTARVY, INN bictegravir/emtricitabine/tenofovir alafenamide

Cresemba, INN Isavuconazole

Delstrigo, INN doravirine/lamivudine/tenofovir disoproxil

Dovato, INN dolutegravir/lamivudine

Erleada, INN Apalutamide

Flutiform, INN Fluticasone, Formoterol

GALAFOLD, INN Migalastat

Lenvima, INN lenvatinib

Libtayo, INN Cemiplimab

ONPATTRO, INN patisiran

Onivyde pegylated liposomal, INN Irinotecan anhydrous free base

PIFELTRO, INN doravirine

Praxbind, INN Idarucizumab

Qtern, INN saxagliptin/dapagliflozin

Quinsair, INN Levofloxacin

Rinvoq, INN Upadacitinib

Roteas, INN edoxaban

Roteas, INN edoxaban, DVT + PE

Suliqua, INN Insulin glargine/lixisenatide

Takhzyro, INN lanadelumab

Translarna, INN ataluren

Vpriv, INN Velaglucerase alfa

Xospata, INN gilteritinib

ZERBAXA, INN Ceftolozane/Tazobactam

  • News
Image

ЗА ЕВРОТО

Information

Careers

Anticorruption

Sitemap

Address

Ak. Ivan Ev. Geshov 15
+ 359 2 8953102
+ 359 2 8953133 (fax)
office @ ncpr.bg
Sofia 1431, Bulgaria

Contacts

  • National council
  • Administration
  • Links
  • Bulgarian institutions and organisations
  • European institutions and organisations

Контакти

Contact us:

See us on a map

world.png

Touched By Touchpoint © 2018-2024 Тъчпойнт. Всички права запазени.